TITLE

QLT GETS POSITIVE OPINIONS FOR QLT091001 AS ORPHAN DRUG

PUB. DATE
March 2011
SOURCE
Worldwide Biotech;Mar2011, Vol. 23 Issue 3, p2
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article provides information on the oral synthetic retinoid, QLT091001, a drug developed by QLT Inc. in Vancouver, British Columbia, for the treatment of two diseases of inherited blindness which include the leber congenital amaurosis (LCA) and retinitis pigmentosa (RP). It reports that the drug has received good reviews from the European Medicines Agency (EMA) and Committee for Orphan Medicinal Products (COMP), as a potential treatment for RP and LCA. More details about RP, LCA, Synthetic Retinoid Drugs and the developer QLT, are provided.
ACCESSION #
58691937

 

Related Articles

  • Subretinal implant benefits retinitis pigmentosa cases. Guttman Krader, Cheryl // Ophthalmology Times;Jun2015, Vol. 40 Issue 10, p15 

    The article focuses on the benefits of subretinal electronic chip implants to blind patients with retinitis pigmentosa. Topics discussed include features of the subretinal chip, comparison of the subretinal device with epiretinal implant, and how the implantation is done following vitrectomy....

  • QLT completes phase la safety trial for LCA therapy.  // Ophthalmology Times;4/15/2009, Vol. 34 Issue 8, p10 

    The article reports on the data from QLT Inc.'s phase Ia clinical trial of QLT091001, a new drug develops by the company for the treatment of Leber's congenital amaurosis (LCA). The data indicates that the study found no serious adverse events, and mild adverse events such as facial flushing and...

  • Help in Sight. Heyman, J.D.; Breu, Giovanna // People;7/15/2002, Vol. 58 Issue 3, p73 

    Focuses on an experimental silicon eye chip which may help correct a common type of blindness called retinitis pigmentosa. Development of the chip by Alan and Vincent Chow, the founders of a company called Optobionics; Way that the chip works; Debbie Bennet's successful experience with the implant.

  • New Stem Cell Approach for Blindness Successful in Mice.  // Chicago Citizen - Chatham Southeast Edition;1/16/2013, Vol. 47 Issue 43, p3 

    The article offers information on a research done by the Oxford University, England researchers in which they transplanted developing cells in mice's eyes and helped them regain their sight. It informs that the approach can be helpful in retinitis pigmentosa treatment which is a condition in...

  • Solving the LCA puzzle: Experimental oral synthetic retinoid shows promise for visual function, behavioral changes. Charters, Linda; Koenekopp, Robert K. // Ophthalmology Times;10/1/2010, Vol. 35 Issue 19, p40 

    The article discusses the development of an experimental oral synthetic retinoid compound (QLT091001) to treat two sub-types of Leber's congenital amaurosis (LCA). It mentions that QLT091001 will replace 11-cis-retinal which is a key chemical in the visual cycle and is lacking in patients with...

  • Brighten dimming vision.  // Prevention;Nov93, Vol. 45 Issue 11, p12 

    Informs on a sight saver that comes from the vitamin shelf. Results of a study reported in `Archives of Ophthalmology,' June 1993, involving 601 patients with retinitis pigmentosa (RP) who were given high doses of vitamins A and E; Researcher Dr. Eliot Berson; Toll-free number for information on RP.

  • Reversing Retinitis Pigmentosa, and a Healthy Guide Dog.  // Gerson Healing Newsletter;Mar/Apr2010, Vol. 25 Issue 2, p8 

    A letter is presented to Charlotte Gerson, founder of the first Gerson clinic, from Carolyn and Hedy, participants of Gerson Therapy, concerning retinitis pigmentosa healing and health restoration for a guide dog.

  • Acupuncture for the treatment of vision loss due to retinitis pigmentosa.  // Ocular Surgery News;8/25/2012, Vol. 30 Issue 16, Special section p8 

    No abstract available.

  • Untitled. Smith, Jeanette M. // JAMA: Journal of the American Medical Association;3/2/94, Vol. 271 Issue 9, p654g 

    Presents an abstract of `Rebound of Macular Edema With Continued Use of Methazolamide in Patients With Retinitis Pigmentosa,' by Gerald A. Fishman and others, which was lifted from an ophthalmology journal. Effect of methazolamide on chronic macular edema; Improvement of macular edema.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics